Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Cancer Litigation over Zantac: US Court gives relief to pharma cos, dismisses thousands of lawsuits

Ruchika Sharma7 Dec 2022 1:10 PM IST

A Sanofi spokesperson said the decision "significantly decreases the scope of the litigation potentially by over 50%," with the remaining litigation...

Pfizer, Clear Creek Bio collaborate for development of COVID oral treatment

Ruchika Sharma7 Dec 2022 12:15 PM IST

Clear Creek Bio will receive an undisclosed upfront payment and will be eligible to receive additional potential milestone payments plus royalties on...

Stryker opens Neurovascular lab to accelerate stroke-related innovation in Asia Pacific

Ruchika Sharma7 Dec 2022 11:15 AM IST

Stroke is a leading cause of death and disability worldwide, with more than 58 million of those cases recorded in Asia.

Inside Coldrif Scandal: Tamil Nadu Plant Used Paint-Grade Chemicals, Violated 300+ Drug Norms

WHO report, samples result on mysterious deaths of Gambia children still pending: Sources

Ruchika Sharma6 Dec 2022 5:30 PM IST

As per sources, India's drug regulator has written several times to the international body but there has been no response.

Bharat Serums Gets CDSCO Panel Nod for Phase III Trial of IVIG in Chronic ITP

Bharat Serums and Vaccines opens Animal Testing Facility, Quality Control Laboratory at Ambernath plant

Ruchika Sharma6 Dec 2022 4:10 PM IST

BSV has also entered into agreements with government-approved vendors for safe disposal of biomedical and other waste generated in the Facility as per...

Cadila Pharma to set up pharma formulation manufacturing unit in Odisha

Ruchika Sharma6 Dec 2022 3:15 PM IST

"The proposed green field pharmaceutical formulations manufacturing unit at Malipada, Bhubaneswar with initial investment of Rs.100 Crores is...

Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents

Ruchika Sharma6 Dec 2022 1:30 PM IST

Pfizer and BioNTech said in their Monday filing that they developed their vaccine independently, calling Moderna's lawsuit "revisionist history" and...

IVF specialist moves Delhi HC against blanket ban on frozen embryo adoption, court seeks centres response

Patent Infringement case: Delhi HC rules in favour of Natco Pharma

Ruchika Sharma6 Dec 2022 12:30 PM IST

New Delhi: Natco Pharma has recently announced that the company has received a favourable verdict from Delhi High Court in a patent infringement...

Boehringer Ingelheim, AnGes sign manufacturing agreement for HGF gene therapy product

CCI approves proposed deal of Bharat Biotech International to acquire Eastman Exports shares

Ruchika Sharma6 Dec 2022 11:39 AM IST

"Given that there are no horizontal overlaps, vertical and/or complementary links between the activities of the BBIL (including its affiliates) and...

Pfizer, BioNTech seek USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in children under 5 years

Ruchika Sharma6 Dec 2022 11:30 AM IST

New York: Pfizer and BioNTech have announced that the companies have submitted an application to the U.S. Food and Drug Administration (USFDA) for...

Biocon Biologics names Shreehas Tambe as new MD, CEO

Ruchika Sharma5 Dec 2022 4:15 PM IST

Bengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced today that Shreehas Tambe, Deputy CEO of Biocon Biologics, has been...

Lupin rolls out Seizure drug Rufinamide in US

Ruchika Sharma5 Dec 2022 3:15 PM IST

Mumbai: Pharma major Lupin Limited today announced the launch of Rufinamide Tablets USP, 200 mg and 400 mg in the United States market.The...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok